PLoS Genetics· 2026Q1
CDH1 Kaybı, İnsan Meme Epitel Hücrelerinde Gen İfadesini ve Soy Kimliğini Yeniden Şekillendirir
CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells
- 4atıf
- Q1SCImago
- 2026yıl
Kısa özet
İnsan meme epitel hücrelerindeki (HMEC) genetik CDH1 kaybı, EMT belirteçlerini indükleyen antikor aracılı inhibisyondan farklı olarak, gen ifadesini lüminal epitel fenotipine doğru yeniden şekillendirir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- HMEC'lerde genetik CDH1 kaybı, EMT belirteçlerini baskılar ve gen ifadesini lüminal epitel fenotipine doğru yeniden şekillendirir.
- Buna karşılık, antikor aracılı E-cadherin inhibisyonu EMT belirteçlerini indükler.
- CDH1 kaybı, hem lüminal hem de bazal HMEC popülasyonlarında soy kimliği yeniden şekillenmesine neden olarak, lüminal progenitor benzeri bir fenotipte birleşir.
- Bu değişim, proliferatif kapasiteyi ve anoikis direncini artırarak erken ILC onkogenezine katkıda bulunur.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Invasive lobular carcinoma (ILC) is a common subtype of breast cancer, molecularly defined by genetic loss of CDH1, and subsequent loss of cell adhesion protein E-cadherin, in ~95% of ILC. Though CDH1 loss occurs early in ILC oncogenesis, it is unclear how this facilitates transformation. We modeled early CDH1 loss using "normal" human mammary epithelial cells (HMEC), i.e., finite lifespan cells reflecting early hyperplasia, and targeted E-cadherin signaling using antibodies versus causing genetic CDH1 loss using siRNA or CRISPR/Cas9-knockout. Transcriptome analysis across four HMEC models showed that the mode of E-cadherin targeting is critical for the subsequent phenotype. Antibody-mediated inhibition of cell-cell contacts induced gene signatures of epithelial-mesenchymal transition (EMT), consistent with the role of E-cadherin suppression during the EMT process. Conversely, genetic CDH1 loss - as in ILC oncogenesis - repressed EMT signatures, and instead remodeled gene expression toward a luminal epithelial phenotype. RNA-seq, single cell transcriptomics, flow cytometry, microscopy, and ATAC-seq analyses support that CDH1 loss induces lineage remodeling to a luminal state, which is mirrored in transcriptomic analysis of clinical ILC precursor lesions. By isolating luminal versus basal cells prior to CDH1 knockout, we found that CDH1 loss led to remodeling of lineage identity in both populations, converging on a new lineage homeostasis with a luminal progenitor-like phenotype. Consistent with the shift to a luminal progenitor phenotype, CDH1 loss enhanced proliferative capacity over the finite lifespan of the HMECs, highlighting a feature of early CDH1 loss that may contribute to clonal advantage during tumor initiation. Moreover, CDH1 loss enhanced anoikis resistance, a defining feature of ILC cells. Our findings support that genetic loss of CDH1 in mammary epithelial cells induces transcriptional and phenotypic changes consistent with lineage identity remodeling toward a luminal progenitor-like state, which may underpin the mechanism by which early CDH1 loss mediates ILC oncogenesis.
Yazarların özeti; kaynağından alınmıştır. PLoS Genetics, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Onkoloji
OncologyMedicine